About Churchill Hospital; Department of Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Churchill Hospital; Department of Oncology
During the past decade, Churchill Hospital; Department of Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)
2016-07-05
2018-12-26
Completed
363
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer
2020-01-29
2025-09-19
Recruiting
400
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
2021-04-26
2025-02-05
Recruiting
554
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
2022-03-07
2027-07-31
Recruiting
56
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Churchill Hospital; Department of Oncology
According to Clinical.Site data, the most researched conditions in "Churchill Hospital; Department of Oncology" are
"Breast Cancer" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Colorectal Cancer" (1 trials) and "Unresectable Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Churchill Hospital; Department of Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Churchill Hospital; Department of Oncology
Most popular intervention types in "Churchill Hospital; Department of Oncology" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an Engineered Anti-PDL1 Antibody" (1 trials), "Cobimetinib" (1 trials), "Fulvestrant" (1 trials) and "Inavolisib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Churchill Hospital; Department of Oncology
The vast majority of trials in "Churchill Hospital; Department of Oncology" are
4 trials for "All" genders.
Clinical Trials Status at Churchill Hospital; Department of Oncology
Currently, there are NaN active trials in "Churchill Hospital; Department of Oncology".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Churchill Hospital; Department of Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Churchill Hospital; Department of Oncology, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".